We have developed novel compounds that possess activity against stroke, post-stroke recovery, and secondary stroke prevention.
These compounds have potential to be used in Traumatic Brain Injury and in combination with clot-dissolving Activase ® , increasing its therapeutic activity and safety.
M3T discoveries also describe lung-brain coupling in CNS injury, where immune cells become activated during trauma, and M3T aerosol formulations can be delivered to treat stroke by Emergency Medical Personnel and administered on-site to trauma and stroke victims where activated immune cells, their inhibition and time are crucial.
Rescuing CNS tissue from Damaging Immune Cells by
M3T Compounds Are a New Treatment Paradigm in Neurodegeneration
Copyright © 2022 M3 Therapeutics - All Rights Reserved.